-transparent.png){kind=logo}
The actions of acridinic acid (2,3-quinoline dicarboxylic acid), a new derivative of quinolinic acid, as an antagonist of amino acid-induced excitations are described. Acridinate, like kynurenate, in the cerebral cortex reduced the effects of all amino acids equally, but in the spinal cord was significantly less active against quisqualate.
Related Publications
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
October 1972,
Brain research,
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
January 1983,
The Journal of physiology,
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
August 1974,
Neuropharmacology,
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
December 1973,
Brain research,
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
April 1970,
British journal of pharmacology,
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
March 1975,
Brain research,
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
July 1988,
Neuroscience letters,
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
January 1977,
Nature,
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
January 1989,
Comparative biochemistry and physiology. A, Comparative physiology,
K Curry, and
D S Magnuson, and
H McLennan, and
M J Peet
July 1978,
The Journal of physiology,
